Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alicia Dudy Müller Veiga
Observed names:
Alicia Dudy Muller Veiga,
Alicia Dudy Müller,
Alicia Muller
Institutions:
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo,
Instituto do Coração - HCFMUSP
Observed institutions:
Universidade de São Paulo,
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo,
Instituto do Coração - HCFMUSP
ORCID:
0000-0003-3528-1837
Observed ORCID:
0000-0003-3528-1837
OpenAlex ID:
A5046594089
Double-blind, Randomized, Placebo-controlled Trial With N-acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19)
2020
·
Julio Cesar Garcia de Alencar
, Claudia de Lucena Moreira
, et al.
·
Clinical Infectious Diseases
·
107
PDF
Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study
2021
·
Felippe Lazar Neto
, Lucas Oliveira Marino
, et al.
·
Clinical Microbiology and Infection
·
60
Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients
2021
·
Maria Clara Saad Menezes
, Alicia Dudy Müller Veiga
, et al.
·
Scientific Reports
·
47
PDF
Timing to Intubation COVID-19 Patients: Can We Put It Off until Tomorrow?
2022
·
Julio Cesar Garcia de Alencar
, Juliana Martes Sternlicht
, et al.
·
Healthcare
·
5
Delirium during Covid-19 pandemic: were we over-reporting an overlooked syndrome?
2022
·
Julio Cesar Garcia de Alencar
, Flávia Barreto Garcez Carvalho
, et al.
·
JBMEDE - Jornal Brasileiro de Medicina de Emergência
·
2
PDF
Effect of Heparin and Tocilizumab in Patients with Severe COVID-19: The HEPMAB Randomized Clinical Trial
2023
·
Lucas Trindade Cantú Ribeiro
, Lucas Trindade Cantú Ribeiro
, et al.
·
medRxiv
·
1
PDF
Show more works
View as search
Works count:
6
Citation count:
222
H-index:
4
I10-index:
3
Year
Topic
Type